Trials / Sponsors / OPKO IP Holdings II, Inc.
OPKO IP Holdings II, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insuff Chronic Kidney Disease, Hyperparathyroidism, Secondary, Vitamin D Deficiency | Phase 3 | 2012-11-01 |
| Completed | Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insuff Chronic Kidney Disease, Hyperparathyroidism, Secondary, Vitamin D Deficiency | Phase 3 | 2012-09-01 |
| Completed | Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic K Chronic Kidney Disease, Secondary Hyperparathyroidism, Chronic Renal Insufficiency | Phase 1 | 2009-05-01 |
| Completed | Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Se Chronic Kidney Disease, Secondary Hyperparathyroidism, Chronic Renal Insufficiency | Phase 1 | 2008-11-01 |
| Completed | Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease Chronic Kidney Disease, Secondary Hyperparathyroidism, Chronic Renal Insufficiency | Phase 2 | 2008-10-01 |